Sientra reported that its net sales more than doubled for the second quarter to $17.6 million, primarily from a 47 percent boost in its miraDry products to $10.9 million. But net losses for the Goleta-based breast implant developer far outpaced analyst expectations at 73 cents per share, or $18 million for the quarter. Operating expenses…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
